Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Mycenax Biotech Inc. (4726) Income Statement

Mycenax Biotech Inc. Income Statement

Last quarter (Q2 2026), Mycenax Biotech Inc.'s total revenue was NT$203.09M, an increase of 0.26% from the same quarter last year. In Q2, Mycenax Biotech Inc.'s net income was NT$-82.59M. See Mycenax Biotech Inc.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 740.24MNT$ 683.92MNT$ 652.62MNT$ 732.28MNT$ 774.27M
NT$ -181.41MNT$ -241.36MNT$ -375.19MNT$ -113.67MNT$ 137.61M
NT$ 222.43MNT$ 220.13MNT$ -375.19MNT$ 300.17MNT$ 230.10M
Depreciation and AmortizationNT$ 284.32MNT$ 303.21MNT$ 314.78MNT$ 282.55MNT$ 167.82M
NT$ -119.51MNT$ -136.46MNT$ -339.48MNT$ -160.34MNT$ 82.83M
NT$ -403.84MNT$ -461.48MNT$ -602.10MNT$ -412.49MNT$ -92.14M
NT$ -50.27MNT$ -8.10MNT$ -81.88MNT$ -49.00MNT$ -2.19M
NT$ -454.11MNT$ -469.59MNT$ -683.98MNT$ -462.84MNT$ -87.52M
NT$ -448.63MNT$ -467.13MNT$ -682.85MNT$ -453.63MNT$ -89.86M
Per Share Metrics
Basic EPSNT$ -2.17NT$ -2.26NT$ -3.32NT$ -2.74NT$ -0.61
Diluted EPSNT$ -2.17NT$ -2.26NT$ -3.32NT$ -2.74NT$ -0.61
Weighted Average Shares Outstanding206.74M206.00M205.53M165.34M148.48M
Weighted Average Shares Outstanding (Diluted)206.74M206.00M205.53M165.34M148.48M

Currency in TWD

Mycenax Biotech Inc. Earnings and Revenue History

-800M0800M1.6B-120 %-60 %0 %60 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin